The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency

Hormone Research

Volumn 60, Issue SUPPL. 1, 2003, Pages 68-73

  Reiter, Edward O ^a   Lindberg, Anders ^b   Ranke, Michael B ^c   Price, David A ^d   Albertsson Wikland, Kerstin ^e   Cowell, Christopher T ^f   Bakker, Bert ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Pharmacia Corporation   (Sweden)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Institute of Endocrinology   (Australia)

Author keywords

Children; Gonadotropin releasing hormone agonists; Growth hormone; Idiopathic growth hormone deficiency; KIGS; Near final height; Pubertal maturation

Indexed keywords

GONADORELIN AGONIST; RECOMBINANT GROWTH HORMONE;

BODY HEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; FEMALE; GROWTH ACCELERATION; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBERTY; SEX DIFFERENCE;

ADOLESCENT; BODY HEIGHT; CHILD; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; GONADOTROPIN-RELEASING HORMONE; GROWTH; GROWTH DISORDERS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; REGISTRIES; SEX CHARACTERISTICS;

EID: 0042413998     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071229     Document Type: Conference Paper

References (36)

1. Bramswig JH, Schlosser H, Kiese K: Final height in children with growth hormone deficiency. Horm Res 1995;43:126-128.
2. Severi F: Final height in children with growth hormone deficiency. Horm Res 1995;43:138-140.
3. Birnbacher R, Riedl S, Frisch H: Long-term treatment in children with hypopituitarism: pubertal development and final height. Horm Res 1998;49:80-85.
4. Blethen SL, Baptista J, Kuntze J, Foley T, LaFranchi S, Johanson A: Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab 1997;82:418-420.
5. De Luca F, Maghnie M, Arrigo T, Lombardo F, Messina MF, Berasconi S: Final height outcome of growth hormone-deficient patients treated since less than five years of age. Acta Paediatr 1996;85:1167-1171.
6. MacGillivray MH, Blethen SL, Buchlis JG, Clopper RR, Sandberg DE, Conboy TA: Current dosing of growth hormone in children with growth hormone deficiency: how physiologic? Pediatrics 1998;102:527-530.
7. Grumbach MM, Bin-Abbas BS, Kaplan SL: The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm Res 1998;49(suppl 2):41-57.
8. Bernasconi S, Arrigo T, Wasniewsk M, Ghizzoni L, Ruggeri C, Di Pasquale G, Vottero A, De Luca F: Long-term results with growth hormone therapy in idiopathic hypopituitarism. Horm Res 2000;53:55-59.
9. August GP, Julius JR, Blethen SL: Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience. Pediatrics 1998;102:512-516.
10. Cutfield WS, Lindberg A, Chatelain P, Price DA, Albertsson-Wikland K, Wilton P, Ranke MB: Final height following growth hormone treatment of idiopathic growth hormone deficiency in KIGS; in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS - 10 Years' Experience. Heidelberg-Leipzig, Johann Ambrosius Barth Verlag, 1999, pp 93-110.
11. Cutfield W, Lindberg A, Albertsson-Wikland K, Chatelain P, Ranke MB, Wilton P: Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board. Acta Paediatr Suppl 1999;428:72-75.
12. Frisch H, Birnbacher R: Final height and pubertal development in children with growth hormone deficiency after long-term treatment. Horm Res 1995;43:132-134.
13. Price DA, Ranke MB: Final height following growth hormone treatment; in Ranke MB, Gunnarsson R (eds): Progress in Growth Hormone Therapy - 5 Years of KIGS. Mannheim, J&J Verlag, 1994, pp 129-144.
14. Burns EC, Tanner JM, Preece MA, Cameron N: Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur J Pediatr 1981;137:155-164.
15. Bourguignon JP, Vandeweghe M, Vanderschuren-Lodeweyckx M, Malvaux P, Wolter R, DuCaju M, Ernould C: Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty. J Clin Endocrinol Metab 1986;63:376-382.
16. Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A: Factors determining pu-bertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Horm Res 1997;48:62-71.
17. Wit JM, Kamp G, Rikken B: Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 1996;39:295-302.
18. Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, Shizume K: The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. J Clin Endocrinol Metab 1989;69: 221-226.
19. Saggese G, Cesaretti G, Andreani G, Carlotti C: Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency. Acta Endocrinol 1992;127: 307-312.
20. Toublanc JE, Couptrie C, Garnier P, Job JC: The effects of treatment combining an agonist of gonadotropin-releasing hormone with growth hormone in pubertal patients with isolated growth hormone deficiency. Acta Endocrinol 1989;120:795-799.
21. Adan L, Souberbielle JC, Zucker JM, Pierre-Kahn A, Kalifa C, Brauner R: Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 1997;82:229-233.
22. Balducci R, Toscano V, Mangiantini A, Municchi G, Vaccaro F, Picone S: Adult height in short normal adolescent girls treated with go-nadotropin-releasing hormone analog and growth hormone. J Clin Endocrinol Metab 1995;80:3596-3600.
23. Saggese G, Pasquino AM, Bertelloni S, Baroncelli GI, Battinin R, Pucarelli I, Segni ME, Franchi G: Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr 1995;84:299-304.
24. Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S: Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J Clin Endocrinol Metab 1996;81:948-951.
25. Job JC, Toublanc JE, Landier F: Growth of short normal children in puberty treated for three years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm Res 1994;41:177-184.
26. Mericq MV, Eggers M, Avila A, Cutler GBJ, Cassorla F: Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 2000;85:569-573.
27. Walvoord EC, Pescovitz OH: Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 1999;104:1010-1014.
28. Codner E, Mericq V, Cassorla F: Optimizing growth hormone therapy during puberty. Horm Res 1997;48:16-20.
29. Mul D, Wit JM, Oostdijk W, Van den Broeck J: The effect of pubertal delay by GnRH agonist in GH-deficient children on final height. J Clin Endocrinol Metab 2001;86:4655-4656.
30. Kohn B, Julius JR, Blethen SL: Combined use of growth hormone and gonadotropin-releasing hormone analogues: the National Cooperative Growth Study Experience. Pediatrics 1999; 104:1014-1017.
31. Conn PM, Crowley WF Jr: Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994;45:391-405.
32. Partsch CJ, Heger S, Sippell WG: Management and outcome of central precocious puberty. Clin Endocrinol (Oxf) 2002;56:129-148.
33. Van der Sluis IM, Boot AM, Krenning EP, Drop SL, De Muinck Keizer-Schrama SM: Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during, and after cessation of GnRH agonist therapy. J Clin Endocri-nol Metab 2002;87:506-512.
34. Heger S, Partsch CJ, Sippell WG: Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Me-tab 1999;84:4583-4590.
35. Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, Adami S, Tato L: Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment. Eur J Endocrinol 1995;133:412-417.
36. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J: High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: A randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 2000;85:3653-3660.